Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis

NCT02473406 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

508

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis, Acute Necrotizing

Interventions

DRUG: Thymosin Alpha 1
DRUG: normal saline

Sponsor

Weiqin Li

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]